| HR (95% CI) | |||
---|---|---|---|---|
Unadjusted | Model 1a | Model 2a | Model 3a | |
FPG tertiles | ||||
 Q1 (referent) | – | – | – | – |
 Q2 | 0.99 (0.78–1.27) | 1.00 (0.78–1.29) | 1.00 (0.77–1.30) | 0.98 (0.75–1.26) |
 Q3 | 1.82 (1.46-2.26)†| 1.81 (1.44-2.26)†| 1.80 (1.43-2.27)†| 1.76 (1.39-2.21)†|
HbA1C tertiles | ||||
 Q1 (referent) | – | – | – | – |
 Q2 | 1.75 (1.31–3.79)†| 1.78 (1.34–2.36)†| 1.79 (1.34–2.39)†| 1.72 (1.29–2.28)†|
 Q3 | 2.92 (2.24–3.79)†| 2.85 (2.18–3.73)†| 2.89 (2.20–3.80)†| 2.70 (2.05–3.54)†|
TyG tertiles | ||||
 Q1 (referent) | – | – | – | – |
 Q2 | 1.42 (1.09–1.86)‡ | 1.46 (1.11–1.92)‡ | 1.46 (1.01–1.92)§ | 1.33 (1.01–1.76)§ |
 Q3 | 2.80 (2.21–3.55)†| 2.81 (2.20–3.60)†| 2.85 (2.22–3.67)†| 2.36 (1.82–3.07)†|
FPG/TyGa | ||||
 Low/low (referent) | – | – | – | – |
 Low/High | 2.10 (1.56–2.83)†| 2.21 (1.63–2.99)†| 2.22 (1.63–3.03)†| 1.89 (1.38–2.59)†|
 High/Low | 1.41 (1.01–1.96)§ | 1.45 (1.03–2.04)§ | 1.43 (1.01–2.03)§ | 1.52 (1.07–2.15)§ |
 High/High | 2.83 (2.22–3.60)†| 2.81 (2.19–3.60) | 2.83 (2.20–3.65)†| 2.48 (1.92–3.21)†|
HbA1C/TyGa | ||||
 Low/low (referent) | – | – | – | – |
 Low/High | 2.13 (1.50–3.01)†| 2.20 (1.54–3.13)†| 2.18 (1.52–3.12)†| 1.92 (1.33–2.77)†|
 High/Low | 2.12 (1.52–2.95)†| 2.12 (1.51–2.97)†| 2.11 (1.50–2.97)†| 2.28 (1.61–3.23)†|
 High/High | 3.99 (3.01–5.29)†| 3.93 (2.94–5.26)†| 3.99 (2.98–5.36)†| 3.79 (2.78–5.17)†|